Jubilant Life shares hit 52-week high on USFDA nod for antidepressant drug

By: |
New Delhi | Updated: Dec 01, 2015 4:40 PM

Jubilant Life Sciences shares soared after the company received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for its generic version of antidepressant Paxil tablets.

USFDA, Jubilant Life Scieces, Jubilan Life shares, bse sensexThe share price of the company climbed as much as 9.75 per cent to Rs 452.40, its 52-week high, on BSE.

Shares of Jubilant Life Sciences hit a new 52-week high on Tuesday after the company informed stock exchanges that it has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for its generic version of antidepressant Paxil tablets.

The share price of the company climbed as much as 9.75 per cent to Rs 452.40, its 52-week high, on BSE.

At 1.38 pm, the share price of Jubilant Life Sciences was up 8.55 per cent at Rs 452.85. The scrip opened at Rs 414 and had touched a high and low of Rs 452.40 and Rs 411.50, respectively, in trade so far. Later, the share price of the company closed 8.67 per cent up at Rs 447.95.

In a release, the company said, “Jubilant Life Sciences has received Abbreviated New Drug Application (ANDA) final approval from the USFDA for Paroxetine Tablets USP, 10 mg, 20 mg, 30 mg and 40 mg, the generic version of Paxil Tablets, 10 mg, 20 mg, 30 mg, and 40 mg® (of Apotex), which is used as an antidepressant.”

As on September 30, 2015, Jubilant Life Sciences had a total of 820 filings for formulations of which 391 have been approved in various regions globally.

This includes 71 ANDAs filed in the US, of which 39 have been approved and 46 Dossier filings in Europe.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Govt open to evaluate, explore cryptocurrencies, says Anurag Thakur
2NMDC leaves iron ore rates unchanged
3Easy Trip Planners IPO opens for subscription Monday; here’s all you need to know